Citation: Jun Mu, Xin Xie, Shanshan Xiong, Yuehua Zhang, Yuting Wang, Qian Zhao, Hongping Zhu, Wei Huang, Gu He. Discovery of spirooxindole–ferrocene hybrids as novel MDM2 inhibitors[J]. Chinese Chemical Letters, ;2021, 32(6): 1897-1901. doi: 10.1016/j.cclet.2021.01.033 shu

Discovery of spirooxindole–ferrocene hybrids as novel MDM2 inhibitors

Jun Mu ^{a, 1} ,
Xin Xie ^{b, 1} ,
Shanshan Xiong ^a ,
Yuehua Zhang ^a ,
Yuting Wang ^b ,
Qian Zhao ^b ,
Hongping Zhu ^b ,
Wei Huang ^{b, *,} ,
Gu He ^{a, *,}

a.
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China
b.
State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China

huangwei@cdutcm.edu.cn

hegu@scu.edu.cn

Received Date: 9 December 2020
Revised Date: 7 January 2021
Accepted Date: 19 January 2021
Available Online: 26 January 2021

Figures(4)

A series of spirooxindole-ferrocene hybrids bearing five or four contiguous chiral centers were designed and synthesized via organocatalysis. In vitro protein binding and cellular proliferation assays suggested that compound 5d was the most potent mouse double minute 2 homolog (MDM2) inhibitor. In addition, mechanistic studies indicated that compound 5d suppressed MDM2-mediated p53 degradation, induced apoptosis and promoted oxidative damage. Molecular docking studies have suggested that 5d binds to MDM2 by mimicking the Trp23 and Leu26 residues of p53. This work can provide a basis for the development of novel multifunctional MDM2 inhibitors. The further exploration of more derivatives from this library and additional investigation of organocatalysis application in the development of new molecules may generate new potential lead compounds for cancer-targeted therapy.
- Spirooxindole,
- Ferrocene,
- MDM2,
- Apoptosis,
- Breast cancer
1. [1]
  G. Jaouen, A. Vessieres, S. Top, Chem. Soc. Rev. 44(2015) 8802-8817. doi: 10.1039/C5CS00486A
2. [2]
  A.C. de Oliveira, E.A. Hillard, P. Pigeon, et al., Eur. J. Med. Chem. 46(2011) 3778-3787. doi: 10.1016/j.ejmech.2011.05.043
3. [3]
  M.A. Richard, D. Hamels, P. Pigeon, et al., ChemMedChem 10(2015) 981-990. doi: 10.1002/cmdc.201500075
4. [4]
  Y. Wang, P. Pigeon, S. Top, M.J. McGlinchey, G. Jaouen, Angew. Chem. Int. Ed. 54(2015) 10230-10233. doi: 10.1002/anie.201503048
5. [5]
  K. Wu, J.Y. Park, R. Al-Saadon, et al., Organometallics 37(2018) 1910-1918. doi: 10.1021/acs.organomet.8b00186
6. [6]
  X.H. He, Y.L. Ji, C. Peng, B. Han, Adv. Synth. Catal. 361(2019) 1923-1957. doi: 10.1002/adsc.201801647
7. [7]
  J.L. Li, Y.Q. Liu, W.L. Zou, et al., Angew. Chem. Int. Ed. 59(2020) 1863-1870. doi: 10.1002/anie.201912450
8. [8]
  X. Zhang, X. Li, J.L. Li, et al., Chem. Sci. 11(2020) 2888-2894. doi: 10.1039/C9SC06377C
9. [9]
  W.J. Luo, B.X. Shao, J.Y. Li, et al., Org. Chem. Front. 7(2020) 1016-1021. doi: 10.1039/D0QO00140F
10. [10]
  R.A. Hussain, A. Badshah, N. Ahmed, et al., Polyhedron 170(2019) 12-24. doi: 10.1016/j.poly.2019.05.027
11. [11]
  P. Chellan, P.J. Sadler, Chemistry 26(2020) 8676-8688. doi: 10.1002/chem.201904699
12. [12]
  W.H. Zhou, X.G. Xu, J. Li, et al., Chin. Chem. Lett. 28(2017) 422-425. doi: 10.1016/j.cclet.2016.09.001
13. [13]
  B. Yu, D.Q. Yu, H.M. Liu, Eur. J. Med. Chem. 97(2015) 673-698. doi: 10.1016/j.ejmech.2014.06.056
14. [14]
  Y.Q. Chen, J.J. Liang, T. Li, et al., Chin. Chem. Lett. 30(2019) 924-928. doi: 10.1016/j.cclet.2019.02.013
15. [15]
  S.P. He, G.Q. Dong, S.C. Wu, et al., J. Med. Chem. 61(2018) 7245-7260. doi: 10.1021/acs.jmedchem.8b00664
16. [16]
  C.J. Ji, S.Z. Wang, S.Q. Chen, et al., Bioorg. Med. Chem. 25(2017) 5268-5277. doi: 10.1016/j.bmc.2017.07.049
17. [17]
  T.T. Liu, Y. Jiang, Z.Z. Liu, et al., Medchemcomm. 8(2017) 1668-1672. doi: 10.1039/C7MD00287D
18. [18]
  W. Liu, S.Q. Chen, F. Zhang, et al., Bioorg. Med. Chem. Lett. 29(2019) 1636-1642. doi: 10.1016/j.bmcl.2019.04.037
19. [19]
  S.Z. Wang, S.Q. Chen, Z.J. Guo, et al., Org. Biomol. Chem. 16(2018) 625-634. doi: 10.1039/C7OB02726E
20. [20]
  S.Z. Wang, Y. Jiang, S.C. Wu, et al., Org. Lett. 18(2016) 1028-1031. doi: 10.1021/acs.orglett.6b00155
21. [21]
  H.P. Zhu, K. Xie, X.H. He, et al., Chem. Commun. (Camb.) 55(2019) 11374-11377. doi: 10.1039/C9CC05916D
22. [22]
  F. Peng, Q. Zhao, W. Huang, et al., Green Chem. 21(2019) 6179-6186. doi: 10.1039/C9GC02694K
23. [23]
  R. Zhou, Q.J. Wu, M.R. Guo, et al., Chem. Commun. (Camb.) 51(2015) 13113-13116. doi: 10.1039/C5CC04968G
24. [24]
  B. Han, W. Huang, W. Ren, et al., Adv. Synth. Catal. 357(2015) 561-568. doi: 10.1002/adsc.201400764
25. [25]
  Y.H. Zhang, C.T. Wang, W. Huang, et al., Org. Chem. Front. 5(2018) 2229-2233. doi: 10.1039/C8QO00422F
26. [26]
  Q. Zhao, C. Peng, H. Huang, et al., Chem. Commun. (Camb.) 54(2018) 8359-8362. doi: 10.1039/C8CC04732D
27. [27]
  G.J. Mei, F. Shi, Chem. Commun. (Camb.) 54(2018) 6607-6621. doi: 10.1039/C8CC02364F
28. [28]
  B. Yu, Z.Q. Yu, P.P. Qi, D.Q. Yu, H.M. Liu, Eur. J. Med. Chem. 95(2015) 35-40. doi: 10.1016/j.ejmech.2015.03.020
29. [29]
  L.M. Zhou, R.Y. Qu, G.F. Yang, Expert Opin, Drug Discov. 15(2020) 603-625.
30. [30]
  Y. Zhao, A. Aguilar, D. Bernard, S. Wang, J. Med, Chem. 58(2014) 1038-1052.
31. [31]
  B.W. Ke, M. Tian, J.J. Li, B. Liu, G. He, Med. Res. Rev. 36(2016) 983-1035. doi: 10.1002/med.21398
1. [1]
  Zhi Li , Shuya Pan , Yuan Tian , Shaowei Liu , Weifeng Wei , Jinlin Wang , Tianfeng Chen , Ling Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018
2. [2]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
3. [3]
  Wenyi Mei , Lijuan Xie , Xiaodong Zhang , Cunjian Shi , Fengzhi Wang , Qiqi Fu , Zhenjiang Zhao , Honglin Li , Yufang Xu , Zhuo Chen . Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells. Chinese Chemical Letters, 2024, 35(5): 108825-. doi: 10.1016/j.cclet.2023.108825
4. [4]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
5. [5]
  Jialin Xie , Qing Feng , Zhen Li , Jinyi Yang , Min Liu , Wei Qi . Life’s Guardian Angel: Progesterone. University Chemistry, 2024, 39(10): 416-419. doi: 10.12461/PKU.DXHX202403068
6. [6]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
7. [7]
  Zhendong Liu , Sainan Liu , Bin Liu , Qi Meng , Meng Yuan , Chunzheng Yang , Yulong Bian , Ping'an Ma , Jun Lin . Fe(Ⅲ)-juglone nanoscale coordination polymers for cascade chemodynamic therapy through synergistic ferroptosis and apoptosis strategy. Chinese Chemical Letters, 2024, 35(11): 109626-. doi: 10.1016/j.cclet.2024.109626
8. [8]
  Yang Liu , Yan Liu , Kaiyin Yang , Zhiruo Zhang , Wenbo Zhang , Bingyou Yang , Hua Li , Lixia Chen . A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2. Chinese Chemical Letters, 2024, 35(8): 109264-. doi: 10.1016/j.cclet.2023.109264
9. [9]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
10. [10]
  Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934
11. [11]
  Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
12. [12]
  Mengjuan Sun , Muye Zhou , Yifang Xiao , Hailei Tang , Jinhua Chen , Ruitao Zhang , Chunjiayu Li , Qi Ya , Qian Chen , Jiasheng Tu , Qiyue Wang , Chunmeng Sun . Reversibly size-switchable polyion complex micelles for antiangiogenic cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109110-. doi: 10.1016/j.cclet.2023.109110
13. [13]
  Haijing Cui , Weihao Zhu , Chuning Yue , Ming Yang , Wenzhi Ren , Aiguo Wu . Recent progress of ultrasound-responsive titanium dioxide sonosensitizers in cancer treatment. Chinese Chemical Letters, 2024, 35(10): 109727-. doi: 10.1016/j.cclet.2024.109727
14. [14]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
15. [15]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
16. [16]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
17. [17]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
18. [18]
  Yihan Zhou , Duo Gao , Yaying Wang , Li Liang , Qingyu Zhang , Wenwen Han , Jie Wang , Chunliu Zhu , Xinxin Zhang , Yong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967
19. [19]
  Boran Cheng , Lei Cao , Chen Li , Fang-Yi Huo , Qian-Fang Meng , Ganglin Tong , Xuan Wu , Lin-Lin Bu , Lang Rao , Shubin Wang . Fluorine-doped carbon quantum dots with deep-red emission for hypochlorite determination and cancer cell imaging. Chinese Chemical Letters, 2024, 35(6): 108969-. doi: 10.1016/j.cclet.2023.108969
20. [20]
  Yuanyi Zhou , Ke Ma , Jinfeng Liu , Zirun Zheng , Bo Hu , Yu Meng , Zhizhong Li , Mingshan Zhu . Is reactive oxygen species the only way for cancer inhibition over single atom nanomedicine? Autophagy regulation also works. Chinese Chemical Letters, 2024, 35(6): 109056-. doi: 10.1016/j.cclet.2023.109056

Get Citation

PDF

XML

Metrics

PDF Downloads(3)
Abstract views(750)
HTML views(81)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142